CORRESP

August 25, 2016

VIA EDGAR

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, N.E.

Mail Stop 4720

Washington, D.C. 20549

 

Attention:

  

Ms. Suzanne Hayes, Assistant Director

Mr. Scot Foley, Attorney-Adviser

 

Re: Acceleration Request of Medicinova, Inc.
     Registration Statement on Form S-3, filed December 1, 2015,
     as amended on December 18, 2015 and August 24, 2016
     (File No. 333-208274)

Ladies and Gentlemen:

Pursuant to Rules 460 and 461 under the Securities Act of 1933, as amended, Medicinova, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effectiveness of the above-referenced Registration Statement, to 4:00 p.m., Eastern Time, on Monday, August 29, 2016, or as soon thereafter as practicable.

The Registrant hereby acknowledges that:

 

    should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

 

    the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

 

    the Registrant may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Thank you for your assistance. If you should have any questions, please contact Ryan Gunderson of Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP, counsel to the Registrant, at (858) 436-8046.

 

Very truly yours,
/s/ Yuichi Iwaki
Yuichi Iwaki
President and Chief Executive Officer